Skip to main content

SOLI - Solithromycin Pediatric Development Program (Phase 2/3)- Labor & Sub Cost

Clinical Trial Grant
Duke Scholars

Administered By

Duke Clinical Research Institute

Awarded By

Cempra Pharmaceuticals, Inc.

Start Date

February 29, 2016

End Date

October 31, 2018
 

Administered By

Duke Clinical Research Institute

Awarded By

Cempra Pharmaceuticals, Inc.

Start Date

February 29, 2016

End Date

October 31, 2018